o 129 has been researched along with kanamycin a in 1 studies
| Studies (o 129) | Trials (o 129) | Recent Studies (post-2010) (o 129) | Studies (kanamycin a) | Trials (kanamycin a) | Recent Studies (post-2010) (kanamycin a) |
|---|---|---|---|---|---|
| 30 | 0 | 2 | 7,169 | 187 | 946 |
| Protein | Taxonomy | o 129 (IC50) | kanamycin a (IC50) |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli K-12 | 6.8 | |
| Gap junction beta-2 protein | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nair, GB; Takeda, Y; Yamamoto, T | 1 |
1 other study(ies) available for o 129 and kanamycin a
| Article | Year |
|---|---|
Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Conjugation, Genetic; Drug Resistance, Multiple; Escherichia coli; Gentamicins; Humans; Kanamycin; Plasmids; Pteridines; R Factors; Sulfamethoxazole; Tetracycline; Tetracycline Resistance; Trimethoprim; Vibrio cholerae | 1995 |